Related Experiment Video
Updated: May 26, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
The Wilson films--Parkinson's disease
1Klinik für Neurologie, Universitätsklinikum Würzburg, Würzburg, Germany. volkmann_j@klinik.uni-wuerzburg.de
Movement Disorders : Official Journal of the Movement Disorder Society
|December 16, 2011
Summary
This study examines the Wilson film's depiction of Parkinson's disease symptoms like bradykinesia and tremor. It explores the historical context and modern understanding of these neurological signs.
Area of Science:
- Neurology
- Medical History
- Film Studies
Background:
- The Wilson film provides visual documentation of neurological conditions.
- Parkinson's disease is characterized by motor symptoms including bradykinesia and tremor.
- Historical medical films offer insights into past clinical observations.
Purpose of the Study:
- To analyze the motivation behind filming Parkinson's disease symptoms in the Wilson film.
- To re-evaluate the clinical presentation of bradykinesia and tremor from a contemporary perspective.
- To bridge historical medical documentation with current neurological understanding.
Main Methods:
- Qualitative analysis of short film sequences.
- Review of historical medical literature on Parkinson's disease.
- Comparison of historical symptom portrayal with current diagnostic criteria.
Main Results:
- The film likely aimed to educate and document the progression of Parkinson's disease.
- Bradykinesia and tremor are clearly illustrated, aligning with core diagnostic features.
- Modern interpretation emphasizes the subjective patient experience and subtle early signs.
Conclusions:
- The Wilson film serves as a valuable historical record of Parkinson's disease.
- Visual evidence from the film aids in understanding the evolution of clinical neurology.
- Revisiting such films enhances our appreciation of both historical and current patient care.
More Related Videos
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...